Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion type Assertion NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_head.
- NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion wasGeneratedBy ECO_0000203 NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_provenance.
- NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion wasDerivedFrom befree-20140225 NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_provenance.
- NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion SIO_000772 11535114 NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_provenance.
- NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion evidence source_evidence_literature NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_provenance.
- NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_assertion description "[Here we review the dosage effects and mutations of the proteolipid protein (PLP) gene that causes Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia Type 2 (SPG2) disorders of CNS myelination.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875838.RA-T1TYUDXHPbnQv3vwXJXFIXjk0Rbw5CeJ2bsXWBFTjQ130_provenance.